Literature DB >> 29578396

Nephritis-associated plasmin receptor (NAPlr) positive glomerulonephritis caused by Aggregatibacter actinomycetemcomitans bacteremia: A case report.

Yohei Komaru, Kunihiro Ishioka, Takashi Oda, Takayasu Ohtake, Shuzo Kobayashi.   

Abstract

Infection-related glomerulonephritis (IRGN) develops after various infections. It was previously thought to be caused by Streptococcus species alone but can also be caused by other pathogens. Nephritis-associated plasmin receptor (NAPlr) was discovered as a candidate nephritis-inducing factor in acute post-streptococcal glomerulonephritis. More recently, renal lesions caused by other pathogens were found to be positive for the same molecular marker. We report the case of a 64-year-old man who experienced repeated fever for several months and presented with progressively-deteriorating renal function. He had previously undergone aortic valve replacement. Aggregatibacter actinomycetemcomitans, a component of the oral flora, was detected in a blood culture. Renal biopsy showed diffuse proliferative glomerulonephritis. Immunofluorescence staining of the kidney specimen was positive for immunoglobulins, complements, and NAPlr. The patient was diagnosed with infectious endocarditis and IRGN. Six weeks of intravenous antibiotic therapy improved the patient's clinical condition and kidney function. In this case, IRGN was caused by a rare pathogen. This is the first published case to show NAPlr positivity in the glomeruli after systemic infection with the periodontal bacteria, Aggregatibacter actinomycetemcomitans. This case and subsequent research might expand the concept of IRGN, anchored by NAPlr as a key diagnostic biomarker.
.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29578396     DOI: 10.5414/CN109173

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

1.  Aggregatibacter actinomycetemcomitans: From Basic to Advanced Research.

Authors:  Abdelhadi Hbibi; Amal Bouziane; Badiaa Lyoussi; Mimoun Zouhdi; Driss Benazza
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis.

Authors:  Anjali A Satoskar; Samir V Parikh; Tibor Nadasdy
Journal:  Nat Rev Nephrol       Date:  2019-08-09       Impact factor: 28.314

Review 3.  Glomerular Deposition of Nephritis-Associated Plasmin Receptor (NAPlr) and Related Plasmin Activity: Key Diagnostic Biomarkers of Bacterial Infection-related Glomerulonephritis.

Authors:  Takahiro Uchida; Takashi Oda
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

4.  Galactose-deficient IgA1 and nephritis-associated plasmin receptors as markers for IgA-dominant infection-related glomerulonephritis: A case report.

Authors:  Wei Han; Tomo Suzuki; Shiika Watanabe; Mayumi Nakata; Daisuke Ichikawa; Junki Koike; Takashi Oda; Hitoshi Suzuki; Yusuke Suzuki; Yugo Shibagaki
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

5.  Use of Immunosuppressive Therapy in the Treatment of IgA-dominant Infection-related Glomerulonephritis.

Authors:  Motohiro Okumura; Shinnosuke Sugihara; Kurumi Seki; Kanako Nagaoka; Naoki Okawa; Masayuki Ebihara; Takahiro Inoue; Junko Fukuda; Mamiko Ohara; Toshiyuki Imasawa; Hiroshi Kitamura; Takashi Oda; Tomo Suzuki
Journal:  Intern Med       Date:  2022-03-01       Impact factor: 1.271

Review 6.  Nephritis-Associated Plasmin Receptor (NAPlr): An Essential Inducer of C3-Dominant Glomerular Injury and a Potential Key Diagnostic Biomarker of Infection-Related Glomerulonephritis (IRGN).

Authors:  Nobuyuki Yoshizawa; Muneharu Yamada; Masayuki Fujino; Takashi Oda
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

7.  Asymptomatic sinusitis as an origin of infection-related glomerulonephritis manifesting steroid-resistant nephrotic syndrome: A case report.

Authors:  Shohei Noda; Shintaro Mandai; Takashi Oda; Tomoko Shinoto; Hidehiko Sato; Keiko Sato; Katsuiku Hirokawa; Yumi Noda; Shinichi Uchida
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.